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ABSTRACT   
 
BACKGROUND: The pharmaceutical bill is increasing at an 
alarming rate. The physician practice variation has a pronounced 
effect on healthcare spending. A number of factors can influence 
the prescribing behavior of physicians. The aim of this review was 
to identify the factors affecting the prescribing decision of 
physicians.  
METHODS: Electronic databases including Scopus, 
PubMed/MEDLINE CENTRAL, Cochrane Libraries and Google 
scholar were searched systematically for literatures on factors 
influencing prescribing decisions of physicians from 2000 to 2016. 
There was no restriction on the study designs.  
RESULTS:  Thirty-three studies met the inclusion criteria from 
1122 search results. A total of 33 factors were identified. The most 
frequent factors were patients’ clinical condition, pharmaceutical 
industries, physician attributes, patient preference and cost of 
medicine. 
CONCLUSION: Physicians’ personal attributes, cost of the 
medicine and pharmaceutical industries’ marketing and 
promotion strategies were mostly mentioned to influence 
prescribing decision. The identified factors showed that 
prescribing is not only geared for patient benefit, but also towards 
personal interest. The use of valid and reliable practice guidelines 
could reduce the negative impact of wide ranges of factors and 
promote the rational prescribing effectively.  
KEYWORDS: prescribing behavior, prescribing decision, 




Prescription medicines have become a major component of health 
systems worldwide. Per capita pharmaceutical expenditures in 
2005/2006 ranged from US$ 7.61 in low-income countries to US$ 
431.6 in high-income countries, with considerable variation between 
income groups in each country (1). On average, the use of 
pharmaceuticals in hospitals and other health care facilities raises 
the pharmaceutical bill by around 20% (2). The rise in 
pharmaceutical expenditure is the result of the amalgamated effect 
of several factors including national and international 
pharmaceutical regulations, pricing policies, the influence of 
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pharmaceutical companies, innovation of new 
drug delivery systems, the emergence of new 
pharmaceuticals for the treatment of previously 
untreated conditions and the prescribers’ decision 
(3-5).  
Physicians are the primary decision makers 
on healthcare resources. Physicians’ prescribing 
decisions are the key for hospitals dominance 
over the health sector market players; 
pharmaceutical companies’ market share; and 
payers target to curb costs (6,7).  The variation in 
physician practice explains the difference in 
expenditure in the health sector (8,9). Patient 
outcome also varies with practice variations 
(9,10). The physician practice variation has a 
pronounced effect on healthcare spending 
increment. However, the connection between 
healthcare spending and outcomes is loose 
(4,6).The physicians’ practice significantly varies 
in medicine prescribing and laboratory procedures 
ordering (11,12).  
The prescribing decision is the result of a 
multitude of intertwined factors such as the 
educational background of prescribers, the 
working environment and so on (13-15). Factors 
influencing prescribers’ decisions are the most 
important input to develop practice guidelines, 
healthcare policy and to devise a regulation for 
the pharmaceutical market. In addition, the 
pivotal-position of physicians makes the study of 
factors which influence prescribing decision of 
tremendous worth. Therefore, highlighting factors 
influencing prescribing decision helps to devise a 
structured way to rationalize patient care process 
and healthcare expenditure.The aim of this review 
was to identify the factors affecting prescribing 




Search strategy: Electronic databases 
(PubMed/MEDLINE CENTRAL, Scopus, 
Cochrane Libraries and Google scholar) were 
searched from 2000 to 2016. The search was done 
by combining the following keywords with 
Boolean operators “AND” and “OR”: Prescribing, 
Prescription, factor, determinant, behavior, 
practice, preferences, inappropriate, optimal, 
pattern, decisions and suggest. Searching in each 
database was adapted to databases characteristics, 
and additionally Medical Subject Headings 
(MeSH) were considered for PubMed.  
Eligibility criteria: The major selection criteria 
were: (1) factors influencing prescribing decision 
should be the main objective, (2) studies should 
be original articles, (3) the full text should be 
available and provide enough information, (4) the 
studies should be written in English, and (5) 
published from 2000 to 2016. 
Selection of articles: The titles and abstracts of 
all records were screened by one reviewer. Then, 
the full texts were selected based on the inclusion 
criteria by two reviewers, independently. 
Discrepancies were settled by discussion and 
consensus including a third reviewer.  
Data abstraction process: Two reviewers, using 
standardized format, separately extracted the 
following information: authors’ name, date of 
publication, study design, aim of the study, 
physician’s specialty, type of medicines, and 
identified factors. 
Validity of selected articles: The heterogeneity 
of the reviewed studies hampers the use of the 
validated tools for quality assessment. 
Nevertheless, the full texts were appraised based 
on the following criteria, and disagreements were 
solved by discussion: 
1. Did the study have sound objective? 
2. Did the study mentioned factors 
influencing prescribing decision clearly? 
3. Did the study clearly describe the setting 
and data sources? 
4. Did the study use reliable methods? 
5. Did the study discuss the validity and the 
limitations of the results? 
 
Data synthesis: The recognized factors affecting 




Selection and characteristics of the studies: The 
search strategy identified 1122 records, and 36 






              
                 Factors Influencing Prescribing Decisisons…                                          Majid D. et al.                                    
 
 

























Figure 1: Bibliographical searches and inclusion process 
 
Validity of selected studies: All the included 
articles had clear objectives, mentioned factors 
influencing prescribing decision clearly, and 
described the setting and data sources. Five studies 
used small samples (11 to 32 study participants) (16-
20). Eleven studies did not describe the 
generalizability and limitation of their findings 
(16,18,21-29).  
Factors influencing prescribing decision: A total 
of 33 factors were identified. Physicians’ personal 
attributes, cost of treatment, pharmaceutical 
industries’ and patients’ preferences were the most 
frequently identified factors to influence prescribing 




This was a review on the factors influencing 
prescribing decisions of physicians. Prescribers 
take the lion’s share in rational pharmaceutical 
use. Prescribers decide the indication of the 
medicine based on the patients’ condition. The 
clinical condition of the patient including the sign 
and symptoms, co-morbid conditions and 
uncertain diagnosis are some of the points looked 
by prescribers before prescribing (17,20,26,31, 
35,36,44). A change in prescribing decision may 
also happen when physicians become in a difficult 
condition to identify the clinical indication of 
medicines or face a fear of complications (52,53). 
Incomplete clinical pictures influence prescribers 
to change their prescribing decision (54).  The 
clinical effectiveness and safety of 
pharmaceuticals are often considered to achieve 
the goal of therapy and enhance the patient 
compliance.  Previous exposure of prescribers to 
the medicine and its past clinical success has a big 
role in altering prescribing decision (16,23,25, 
34,41,50). It was shown that the use of diagnostic 
procedures for identification of the clinical 
condition and valid clinical guidelines fosters the 





Full texts selected =50 
 
Selected articles for review=36 
 
Excluded at full text=14 
 
Titles and abstracts for 
screening=983 Excluded by title screening=815 
Excluded by abstract 
screening=118 
 
Excluded as duplicate 
between databases=139 
 
Total number of articles from 
databases=1122 
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Identified factor  Articles Frequency  
1.  Personal attributes** (19, 23, 26, 29-32, 35, 38, 39, 41, 46, 48, 
49, 51) 
15 
2.  cost of treatment  (20, 26, 28-30, 34, 36-39, 42, 44, 48) 13 
3.  Patient preference (20, 23, 25, 26, 28, 30, 32, 36, 37, 39, 44, 
48) 
12 
4.  Pharmaceutical industries (20, 26, 28, 31, 36, 38, 39, 42, 44, 47, 48) 11 
5.  Head of the departments and colleagues (20, 23, 27, 30, 31, 39, 47, 51) 8 
6.  patient's or families expectation (18, 19, 23, 33, 38, 47, 50, 51) 8 
7.  Patient’s clinical condition (23, 26, 34, 35, 41, 43, 50) 7 
8.  Clinical effectiveness and safety of the drug (25, 28, 29, 34, 36, 39, 48) 7 
9.  Practice guidelines and policies (19, 21, 23, 29, 32, 42, 48) 7 
10.  Patients insurance coverage  (17, 35, 36, 39, 47, 51) 6 
11.  Willingness to involve patients in decision-
making 
(19, 23, 31, 46, 47, 50) 6 
12.  Drug’s indication  (26, 33, 34, 42, 47) 5 
13.  Available resources and practice location (23, 28, 39, 51) 4 
14.  Pharmaceutical attributes* (28, 36, 47, 51) 4 
15.  Preferred Information sources (26, 28, 31, 36) 4 
16.  Socio-demography of patients (27, 49, 51) 4 
17.  Diagnostic procedures (21, 23, 47) 3 
18.  Financial incentives (21, 39, 41) 3 
19.  Patients ease of access to drug therapy (19, 21, 43) 3 
20.  Time constraint (20, 32, 43) 3 
21.  Resistance and treatment failure (21, 26) 2 
22.  Patients past experience with medication (25, 48) 2 
23.  Higher ratio of specialists to general physicians (27, 39) 2 
24.  Political and administrative influence (23, 39) 2 
25.  Patient knowledge (27, 33) 2 
26.  Patient's ability to take the drug (42, 47) 2 
27.  Clinicians’ professionals ethos (19) 1 
28.  Number of doctors or doctor per patient (41) 1 
29.  Physicians general attitudes towards the health 
system 
(46) 1 
30.  Preference for local company (26) 1 
31.  Curiosity about the drug (26) 1 
32.  Personal ‘head-held’ drug formulary (20) 1 
33.  participation in clinical trial (39) 1 
 
*the dose, frequency, rout of administration and monitoring requirement of the drug 
**experience, specialty, continuous professional development and area of interest of physician  
 
 
A number of factors associated with the working 
and external environment that influence 
prescribing decision were highlighted in this 
review. It is a well-established fact that learning 
organizations and organizational structures 
increase the performance of employees (55). 
Availability of diagnostic and pharmaceutical 
resources in the organization could also influence 
the prescribing decision of physicians 
(27,34,35,48,50). Pharmaceutical companies try  
 
to influence the prescribing decision of 
prescribers by creating a mutual benefit based 
relationship (39). The pharmaceutical companies 
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need the relationship to show how differentiated 
their products are and to increase their market 
share. Pharmaceutical companies usually do face-
to-face detailing, provide medicine samples, 
provide written evidence, organize meetings, 
organize medicine launches, sponsor continuous 
medical education and provide gifts (5,15,56,57). 
The type of advertising and promotion strategies 
is dynamic based on the physicians’ reactions 
(58). 
Clinical guideline development needs 
considerable heedfulness. Clinical guidelines that 
limit the discretion of prescribers will have 
doubtful implementation. It was revealed that 
physicians’ involvement in hospital decision 
making process and development of hospital 
specific guidelines influence their prescribing 
decision (37). Physicians adhere more to the 
guidelines which their reflection was considered 
(32). Furthermore, feedback on the prescribing 
behavior based on agreed and reflected criteria 
improves the prescribing behavior more than mere 
distribution of guidelines (32,59,60). 
The physicians’ attributes which include the 
clinical experience, specialty, continuous 
professional development and practice decision 
was the most frequently mentioned prescriber 
related factor. Clinical experience outlined as a 
factor to influence prescribing decision by most of 
the reviewed articles (16,18,26,33,43,44,47). The 
exposure of physicians for different class of 
medicines and patient outcome are expected to 
increase with increased clinical experience and 
years of service.  Hoever, a single study claimed 
that the quality of care decrease with increased 
clinical experience (61). Experience leads to a 
personal, informal medicine list, which may 
conflict with new guidelines (22). Specialist 
physicians’ influence on prescribing decisions is 
expected to be high. Especially, in new medicine 
prescribing, most of the general practitioners are 
dependent on what was said by specialists (62). 
Physicians’ perceptions of patient expectation 
influence their prescribing behavior (17), which is 
a stronger predictor of prescribing than patient 
perception(63). Physicians prescribe not to risk 
their relationship with patients when they perceive 
prescription is required (64). The information 
sources used by physicians have an important role 
in altering their prescribing decisions 
(16,41,43,44,50). Although medical reference 
books and scientific literatures have a large 
theoretical importance, colleagues, clinical 
meetings and medical representatives are key 
sources of information used to prescribe new 
medicines (65). Information from pharmaceutical 
companies increases awareness on available 
medicines in the market. However, this 
information may turn physicians to high 
prescribers, high cost prescribers and low 
prescribing quality practitioners (66). Physicians’ 
interest in a particular area and involvement in 
clinical trial are also important factors for new 
medicine prescribing (67).  
In the current review a number of factors 
associated with the patient or the care givers were 
identified: the socio-demographic status, 
knowledge of patient about medicines, 
expectation and request to a particular treatment. 
The patient socio-demographics such as age, sex, 
social status has to be considered for better quality 
of care(23,27,36,47). The knowledge of the 
patient on pharmaceutical products makes the 
patient request for a specific medication and alters 
patient expectations (17,23,68). Generally, 
patients who expect prescription are more likely 
to have it(69,70). Patient’s pressure on physicians 
may lead to unnecessary prescribing and 
referral(63); but, the transition from the old 
paternalistic care to engagement of patients in 
decision making has increased the role of patients 
as an actor in decision making (71). Some studies 
showed that the involvement of patients in their 
care selection made physicians to change 
prescribing decision(69,70). Likewise, self-
medication practice towards antibiotics has made 
physicians to let the patient continue the 
unnecessary antibiotics to prevent resistance or to 
change the regimen to the more potent medicine 
due to the perception of resistance(19,45).  
The other factors identified are associated 
with the economic conditions: cost, insurance and 
financial incentives.  The cost of a medicine to a 
patient is usually considered by physicians during 
prescribing (16,21,22,26,31,34,35,41,44,48,50). 
Insurance, in general, was found to influence the 
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selection of type and quantity of health care 
utilization and also improve health (72). The level 
of reimbursement of pharmaceuticals affects the 
prescribing decision of physicians. Insured 
patients consume more health care service than 
uninsured patients with a lower expenditure (73). 
The financial incentives for the prescriber are 
motives that influence the prescribing behavior 
and could increase induced demand (19). 
Financial incentives can be given by lower 
copayments for patients who choose medicines 
preferred by the payer (74). Financial incentives 
can also be achieved by physician payment 
modalities and health care financing systems. 
Capitation payment for each patient registered had 
shown a reduction in prescription costs (75).  
Our findings showed that many factors can 
influence the prescribing decisions of physicians. 
These factors can be used in policy development 
to enhance the prescribing decision of prescribers.  
Factors may or may not give chance for change. 
Demographic characteristics and socioeconomic 
factors give a little room for improvement 
(56,76). However, factors like knowledge, 
educational level, experience, the number of 
practicing professionals, cost sharing and 
guidelines can be modified to influence 
prescribing behavior.   
The review included only articles published 
in the English language which might introduce 
bias. The studies included in the review had a 
different study design, data collection, analysis 
technique and many of them were done with a 
few classes of medicines. The factors level of 
influence on the prescribing decision was not 
included in this review. 
Physician’s personal attributes, cost of the 
medicine, and pharmaceutical industries’ 
marketing and promotion strategies were mostly 
mentioned to influence prescribing decision. The 
identified factors showed prescribing is not only 
geared for patient benefit, but also towards 
physician’s interest. The use of valid and reliable 
practice guidelines could reduce the negative 
impact of wide ranges of factors and promote the 
rational prescribing effectively. Studies on 
causative relationship between identified factors 
and prescribing decision may be a very effective 
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